Search by Drug Name or NDC

    NDC 51655-0696-52 Levothyroxine Sodium 0.125 mg/1 Details

    Levothyroxine Sodium 0.125 mg/1

    Levothyroxine Sodium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is LEVOTHYROXINE SODIUM.

    Product Information

    NDC 51655-0696
    Product ID 51655-696_f7e31fee-2e20-a2ac-e053-6294a90a8c63
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Levothyroxine Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Levothyroxine Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 0.125
    Active Ingredient Units mg/1
    Substance Name LEVOTHYROXINE SODIUM
    Labeler Name Northwind Pharmaceuticals
    Pharmaceutical Class Thyroxine [CS], l-Thyroxine [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021210
    Listing Certified Through 2024-12-31

    Package

    NDC 51655-0696-52 (51655069652)

    NDC Package Code 51655-696-52
    Billing NDC 51655069652
    Package 30 TABLET in 1 BOTTLE, PLASTIC (51655-696-52)
    Marketing Start Date 2021-04-01
    NDC Exclude Flag N
    Pricing Information N/A